BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.169
-0.001 (-0.59%)
Mar 9, 2026, 12:43 PM EST
BioLargo Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.88 | 3.55 | 3.54 | 1.85 | 0.96 | Upgrade
|
| Cash & Short-Term Investments | 3.88 | 3.55 | 3.54 | 1.85 | 0.96 | Upgrade
|
| Cash Growth | 9.44% | 0.25% | 91.19% | 92.41% | 34.36% | Upgrade
|
| Receivables | 0.62 | 3.17 | 2.61 | 1.06 | 0.51 | Upgrade
|
| Inventory | 0.31 | 0.33 | 0.15 | 0.12 | 0.24 | Upgrade
|
| Prepaid Expenses | 0.31 | 0.09 | 0.06 | 0.12 | 0.09 | Upgrade
|
| Total Current Assets | 5.11 | 7.14 | 6.36 | 3.15 | 1.8 | Upgrade
|
| Property, Plant & Equipment | 3.01 | 3.19 | 1.75 | 1.15 | 0.51 | Upgrade
|
| Long-Term Investments | - | 0.01 | 0.02 | 0.03 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0.19 | 0.18 | 0.07 | 0.52 | 0.66 | Upgrade
|
| Total Assets | 8.31 | 10.51 | 8.21 | 4.86 | 3.02 | Upgrade
|
| Accounts Payable | 2.8 | 1.07 | 1.35 | 0.9 | 0.5 | Upgrade
|
| Accrued Expenses | - | 0.15 | 0.3 | 0.28 | 0.29 | Upgrade
|
| Current Portion of Long-Term Debt | 1.48 | 0.55 | 0.3 | 0.1 | 0.31 | Upgrade
|
| Current Portion of Leases | 0.31 | 0.19 | 0.11 | 0.1 | 0.1 | Upgrade
|
| Current Unearned Revenue | 0.28 | - | 0.3 | 0.02 | 0.09 | Upgrade
|
| Other Current Liabilities | 0.19 | 0.68 | 0.36 | 0.18 | 0.08 | Upgrade
|
| Total Current Liabilities | 5.06 | 2.65 | 2.71 | 1.58 | 1.37 | Upgrade
|
| Long-Term Debt | 0.6 | 0.53 | 0.29 | 0.5 | 0.37 | Upgrade
|
| Long-Term Leases | 1.12 | 1.28 | 1 | 0.77 | 0.35 | Upgrade
|
| Total Liabilities | 6.79 | 4.46 | 4 | 2.85 | 2.09 | Upgrade
|
| Common Stock | 0.21 | 0.2 | 0.2 | 0.19 | 0.17 | Upgrade
|
| Additional Paid-In Capital | 165.32 | 158.33 | 154.02 | 148.44 | 143.72 | Upgrade
|
| Retained Earnings | -161.28 | -149.5 | -147.1 | -143.59 | -139.12 | Upgrade
|
| Comprehensive Income & Other | -0.21 | -0.18 | -0.28 | -0.15 | -0.12 | Upgrade
|
| Total Common Equity | 4.04 | 8.85 | 6.84 | 4.88 | 4.65 | Upgrade
|
| Minority Interest | -2.52 | -2.8 | -2.64 | -2.87 | -3.72 | Upgrade
|
| Shareholders' Equity | 1.53 | 6.06 | 4.2 | 2.01 | 0.93 | Upgrade
|
| Total Liabilities & Equity | 8.31 | 10.51 | 8.21 | 4.86 | 3.02 | Upgrade
|
| Total Debt | 3.51 | 2.55 | 1.7 | 1.47 | 1.13 | Upgrade
|
| Net Cash (Debt) | 0.37 | 0.99 | 1.84 | 0.38 | -0.17 | Upgrade
|
| Net Cash Growth | -62.78% | -46.01% | 380.68% | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 319.75 | 301.3 | 295.55 | 283.19 | 262.72 | Upgrade
|
| Total Common Shares Outstanding | 317.38 | 301.27 | 292.95 | 278.46 | 255.89 | Upgrade
|
| Working Capital | 0.05 | 4.49 | 3.65 | 1.58 | 0.43 | Upgrade
|
| Book Value Per Share | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Tangible Book Value | 4.04 | 8.85 | 6.84 | 4.88 | 4.65 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.